Pharsight

Drug Patents owned by Redhill

1. List of Aemcolo drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8263120 REDHILL Oral antimicrobial pharmaceutical compositions
May, 2025

(1 year, 11 months from now)

US8741948 REDHILL Oral antimicrobial pharmaceutical compositions
May, 2025

(1 year, 11 months from now)

US8486446 REDHILL Oral antimicrobial pharmaceutical compositions
May, 2025

(1 year, 11 months from now)

US8529945 REDHILL Oral antimicrobial pharmaceutical compositions
May, 2025

(1 year, 11 months from now)

Do you want to check out AEMCOLO patents from before 2022?
Exclusivity Exclusivity Expiration
New Chemical Entity Exclusivity (NCE) Nov 16, 2023
Generating Antibiotic Incentives Now (GAIN) Nov 16, 2028

Drugs and Companies using RIFAMYCIN SODIUM ingredient

NCE-1 date: 2027-11-17

Market Authorisation Date: 16 November, 2018

Treatment: Treatment of travelers' diarrhea caused by non-invasive strains of escherichia coli in adults

Dosage: TABLET, DELAYED RELEASE;ORAL

More Information on Dosage

AEMCOLO family patents

10

United States

3

European Union

2

China

2

Canada

2

Japan

2

Korea, Republic of

1

Italy

1

Spain

1

Austria

1

Denmark

1

RS

1

Germany

1

Poland

1

Croatia

1

Cyprus

1

Portugal

1

Mexico

1

South Africa

1

Slovenia

1

Hungary

2. List of Movantik drug patents

MOVANTIK's oppositions filed in EPO
MOVANTIK Litigations
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7662365 REDHILL Polymer conjugates of opioid antagonists
Oct, 2022

(7 months ago)

US7786133 REDHILL Chemically modified small molecules
Sep, 2028

(5 years from now)

US9012469 REDHILL Crystalline naloxol-peg conjugate
Apr, 2032

(8 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8617530 REDHILL Polymer conjugates of opioid antagonists
Oct, 2022

(7 months ago)

US7056500 REDHILL Polymer conjugates of opioid antagonists
Jun, 2024

(1 year, 1 month from now)

US8067431 REDHILL Chemically modified small molecules
Dec, 2024

(1 year, 6 months from now)

Do you want to check out MOVANTIK patents from before 2022?

Drugs and Companies using NALOXEGOL OXALATE ingredient

Market Authorisation Date: 16 September, 2014

Treatment: Treatment of opioid-induced constipation

Dosage: TABLET;ORAL

How can I launch a generic of MOVANTIK before it's patent expiration?
More Information on Dosage

MOVANTIK family patents

22

United States

8

European Union

7

Spain

6

Australia

4

Hong Kong

4

Denmark

4

China

4

Canada

4

Japan

4

New Zealand

4

Korea, Republic of

4

Cyprus

4

Portugal

4

Slovenia

EA

3

EA

2

RS

2

Poland

2

Croatia

2

Israel

2

Mexico

2

Lithuania

2

Hungary

1

Uruguay

1

Malaysia

1

Brazil

1

Ukraine

1

Singapore

1

Argentina

1

ME

1

Nicaragua

1

San Marino

1

Guatemala

1

Peru

1

Chile

1

Taiwan

1

Sweden

1

Cuba

1

Costa Rica

1

Ecuador

1

Netherlands

1

South Africa

1

Colombia

1

Luxembourg

3. List of Talicia drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10238606 REDHILL Pharmaceutical compositions for the treatment of Helicobacter pylori
Feb, 2034

(10 years from now)

US11135172 REDHILL Rifabutin-based compositions and methods for treating Helicobacter pylori infection
Feb, 2034

(10 years from now)

US9050263 REDHILL Pharmaceutical compositions for the treatment of Helicobacter pylori
Feb, 2034

(10 years from now)

US9603806 REDHILL Pharmaceutical compositions for the treatment of Helicobacter pylori
Feb, 2034

(10 years from now)

US9498445 REDHILL Pharmaceutical compositions for the treatment of Helicobacter pylori
Feb, 2034

(10 years from now)

Do you want to check out TALICIA patents from before 2022?

Drugs and Companies using AMOXICILLIN; OMEPRAZOLE MAGNESIUM; RIFABUTIN ingredient

Market Authorisation Date: 01 November, 2019

Treatment: Treatment of h. pylori infection in adults

Dosage: CAPSULE, DELAYED RELEASE;ORAL

More Information on Dosage

TALICIA family patents

10

United States

2

China

1

Spain

1

Hong Kong

1

Philippines

1

Denmark

1

Poland

1

Russia

1

Brazil

1

Canada

1

Ukraine

1

Singapore

1

Japan

1

New Zealand

1

Croatia

1

Korea, Republic of

1

Israel

1

Chile

1

Portugal

1

Mexico

1

Australia

1

Slovenia

1

Hungary

1

European Union

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic